HBIO

Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M

5 hours ago

Harvard Bioscience reports Q4 loss of $0.06/share on revenue of $23.7M, down 3.3% year-over-year, with Q1 guidance suggesting continued pressure.

Harvard Bioscience Inc (HBIO) Q2 2022 Earnings conference

4 years ago

Harvard Bioscience Inc (NASDAQ: HBIO) Q2 2022 Earnings Conference

Harvard Bioscience Inc (HBIO) Q1 2022 earnings call

4 years ago

Harvard Bioscience Inc (NASDAQ: HBIO) Q1 2022 Earnings Conference

Harvard Bioscience Inc (HBIO) Fourth Quarter 2021 Earnings Conference Call

4 years ago

Harvard Bioscience Inc (NASDAQ: HBIO) Q4 2021 Earnings Conference

Harvard Bioscience Inc (HBIO) Q3 2021 Earnings call

4 years ago

Harvard Bioscience Inc (NASDAQ: HBIO) Q3 2021 Earnings Conference

Harvard Bioscience Inc (HBIO) Q2 2021 Harvard Bioscience, Inc. Earnings Conference Call

5 years ago

Harvard Bioscience Inc (NASDAQ: HBIO) Q2 2021 Earnings Conference

Harvard Bioscience Inc (HBIO) Harvard Bioscience Announces Fourth Quarter 2020 Financial Results

5 years ago

Harvard Bioscience Inc (NASDAQ: HBIO) Q4 2020 Earnings Conference